EXAI - Exscientia files for $300M mixed shelf offering
2024-03-21 11:12:18 ET
More on Exscientia
- Exscientia: A Strategic Hold In The AI-Driven Drug Discovery Sector (Rating Downgrade)
- Exscientia FY 2023 Earnings Preview
- Anagenex expands leadership team with appointment of Adrian Schreyer as CTO
- Seeking Alpha’s Quant Rating on Exscientia
- Historical earnings data for Exscientia